Head to head for first-timers
CoreAge Rx vs NuuVim
CoreAge Rx and NuuVim both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxNuuVim
Rank #108 for first-timers · Grade C
Mama-Match
Best for: Moms looking for the lowest entry price to try a GLP-1, who don't mind not yet knowing the price after the first period.
Visit NuuVimThe verdict for a first step
CoreAge Rx edges out NuuVim on the Mama-Match Score, 94 to 55 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
NuuVim is still a genuine option — the lowest new-patient price on this roster — $79/mo semaglutide, $133/mo tirzepatide — with the genuine rarity of charging the same for an oral tablet as for the injection, though it doesn't publish the refill rate or a verifiable state list. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | NuuVim |
|---|---|---|
| Mama-Match Score | 94/100 · A | 55/100 · C |
| Overall rank | #1 | #108 |
| Semaglutide | $99/mo | $79/mo |
| Tirzepatide | $149/mo | $133/mo |
| Coverage | All 50 states | Not confirmed live (see note) |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
NuuVim
Rank #108 · Grade C
What we like
- The lowest new-patient price on this roster: $79/mo semaglutide, $133/mo tirzepatide
- Same price for the oral tablet as for the injection — a genuine rarity in this category
- LegitScript certification and HIPAA compliance
The caveats
- Doesn't publish the refill rate — the low price is specifically for new patients
- A list of states served couldn't be verified live
- Its brand-name options (Ozempic, Zepbound) cost far more than the manufacturer's direct self-pay channels
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and NuuVim with the other providers we review for women.
Or browse the full comparison hub.